Navigation Links
GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
Date:8/7/2009

1 human clinical trials investigating the therapeutic vaccine approach. Our reassessment of the time required to gain approval from the FDA is such that we expect this trial to begin during the first quarter of 2010. Our plan is to produce data from our therapeutic vaccine trials in support of future capital-raising and corporate partnering efforts."

Dr. McNally concluded, "Continued funding of our clinical programs and research and development efforts is critical. At the same time, we are diligently managing our cash outlays. Our financial condition is stable, with the ongoing support provided by HVTN (through their conduct of our Phase 2a trial), the five-year $17 million grant to GeoVax from the National Institutes of Health (NIH), awarded in late 2007, and the equity financing facility with Fusion Capital Fund II, LLC. We are pursuing a number of funding options to accelerate our therapeutic vaccine clinical trials program. The latest of which was a proposed cooperative arrangement with Cook County (metro Chicago), the Cook County Health and Hospitals System, and the Ruth M. Rothstein's CORE Foundation. Although it now appears that our original proposal will not progress, it is an example of the type of initiative we will continue to pursue. We remain in discussions with various Cook County-based parties and continue to explore related funding opportunities."

Review of Financial Results

The Company recorded a net loss of $1,348,654 for the three months ended June 30, 2009, compared to $1,284,352 for the same period in 2008. For the six months ended June 30, 2009, the Company's net loss was $2,210,163 as compared to $1,966,862 in 2008. Net losses were partially offset by grant revenues related to the Company's grant from the NIH in support of its HIV/AIDS vaccine development activities; such revenues were $752,800 and $1,462,955 for the three month and six month periods of 2009, respectively,
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow
2. Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership
3. Scarguard Labs, LLC Appoints Richard E. Pino as CFO
4. Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
5. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
6. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
7. NATB Announces Partnership With Ronald McDonald House Charities(R)
8. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
9. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
10. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
11. AMN Healthcare Announces Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 One of the ... of bioactive material, making it useful in different application ... and tissue engineering. , Analysts forecast the Global ... of 13.30 percent over the period 2013-2018. According to ... the major drivers in the market. There will be ...
(Date:9/19/2014)... Ohio Couples and other adult family members living ... as adults living with young children or adolescents to ... the week, new research suggests. , The study is ... American adults. While a substantial amount of research has ... family meals, such eating patterns have not been widely ...
(Date:9/19/2014)... CA (PRWEB) September 19, 2014 AttorneyOne.com, a ... the latest information from the FDA on Potassium Chloride ... Baxter International Inc. recalled one lot of Potassium ... on the shipping cartons. Potassium Chloride, administered intravenously, is used ... recall is based on a labeling error on the shipping ...
(Date:9/19/2014)... 19, 2014 Final Cut Pro X plugin ... the Float Theme template for Apple's Final Cut Pro ... template that allows FCPX users to create a professional themed ... Austin, CEO of Pixel Film Studios, "With 48 camera options ... with the Float Theme." , Float features all of ...
(Date:9/19/2014)... Yisrayl Hawkins, Pastor of The House of Yahweh wrote ... protect children. He begins by encouraging the reader not to ... there are many other children, like Michael Brown, who are ... than cancer all over the world and must be stopped ... billion Michaels in the world who were left to themselves ...
Breaking Medicine News(10 mins):Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 3Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 4Health News:Even without kids, couples eat frequent family meals 2Health News:Even without kids, couples eat frequent family meals 3Health News:Even without kids, couples eat frequent family meals 4Health News:Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Pixel Film Studios Releases Float Theme for Final Cut Pro X Users 2Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2
... 4 p.m. EDT) Myelodysplastic syndromes (MDS) a group of ... common in seniors than previously thought, according to a new ... Hackensack University Medical Center. The study also showed for ... risk for heart attack, diabetes and other serious complications than ...
... blockages , MONDAY, April 26 (HealthDay News) -- It,s ... other parts of the body, and researchers now have ... smoking causes progressive stiffening of the arteries. , ... double the speed of those of nonsmokers, Japanese researchers ...
... vital ingredient, researchers believe , MONDAY, April 26 (HealthDay ... rice -- may reduce the risk of heart disease and ... those conditions, research suggests., , In a new study, researchers ... better than white rice when it comes to protecting the ...
... mishaps increase along with distractions, study finds , MONDAY, ... during taxi, takeoff or landing could lead to a ... who prepare and administer medication to hospital patients. ... they,re tending to patients, medication needs increases the chances ...
... Society for Radiation Oncology (ASTRO) applauds President Obama,s selection ... of the Centers for Medicare and Medicaid Services. ASTRO ... administration and Congress to implement critical healthcare reforms for ... across providers to improve the quality of care patients ...
... The American Society of Pediatric Otolaryngology (ASPO) will hold ... the 2010 Combined Otolaryngology Spring Meetings (COSM) - a ... NV. During the ASPO meeting, hundreds of ... featuring expert panelists will be presented focusing on children,s ...
Cached Medicine News:Health News:MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought 2Health News:MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought 3Health News:Arteries Age Twice as Fast in Smokers 2Health News:Arteries Age Twice as Fast in Smokers 3Health News:Interrupting a Nurse Makes Medication Errors More Likely 2Health News:Interrupting a Nurse Makes Medication Errors More Likely 3Health News:Interrupting a Nurse Makes Medication Errors More Likely 4Health News:Scientific meeting will host new research in children's ear, nose and throat health 2
(Date:9/18/2014)... 2014 MiMedx Group, Inc. (NASDAQ: ... marketer of patent protected regenerative biomaterials and bioimplants ... it has entered into a distribution agreement with ... its dehydrated human amnion/chorion membrane ("dHACM") allograft products ... a private label basis. The MiMedx ...
(Date:9/18/2014)... 2014  Zacks.com announces the list of stocks featured ... Research analysts discuss the latest news and events impacting ... the blog include the Avanir Pharmaceuticals (Nasdaq: AVNR - ... Free Report ), Orexigen (Nasdaq: OREX - Free ... ) and Gilead (Nasdaq: GILD - Free Report ...
(Date:9/18/2014)... YORK and PLAINSBORO, N.J. ... announced today its support of the National Hemophilia ... Care , which provides support to people with ... physical and psychosocial challenges that can impede disease ... six modules, Communication With Your Provider About ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3
... level of blood oxygenation can be an essential ... in the clinical setting is often desirable. In ... technology into easily used point-of-care devices, recent products ... values., ,HemoCue, Inc., Lake Forest, Calif., says that ...
... the context of many clinical laboratories, automated production in ... years. In automobile assembly, for example, automated lines fabricate ... The result has been vastly improved products, far fewer ... These days, only a handful of luxury and sports ...
Cached Medicine Technology:Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... best value in high performance electronic pipetting!, ... lightweight design reduce hand fatigue and strain ... tip ejector , Color coding for easy ... for greater performance use Hamilton AdvanTip Low ...
... The Finnpipette BioControl ... innovative features as the ... universal handle fits all ... single channel tip cone ...
... Entire Column of a 384 Well Plate at ... 384 well plates, you need a pipettor that ... exactly what you get with our 16-channel Impact ... Impact/Impact2), this innovation was specifically designed to allow ...
Medicine Products: